Metoprolol Succinate Dosing Strengths and Recommendations
Metoprolol succinate extended-release tablets are available in 25 mg, 50 mg, 100 mg, and 200 mg strengths, administered once daily. 1
Available Tablet Strengths
The FDA-approved formulation provides the following strengths 1:
- 25 mg tablets (white, film-coated, scored)
- 50 mg tablets
- 100 mg tablets
- 200 mg tablets
All tablets are scored and can be divided, but must be swallowed whole—never chewed or crushed 1.
Dosing by Indication
Hypertension
Starting dose: 25-100 mg once daily 1
- May be used alone or combined with a diuretic
- Titration: Increase at weekly intervals until optimal blood pressure control
- Maximum studied dose: 400 mg daily 1
- Maximum effect of any dose appears after 1 week of therapy 1
The 2018 ACC/AHA hypertension guidelines confirm a usual dose range of 50-200 mg once daily for metoprolol succinate 2, 3.
Angina Pectoris
Starting dose: 100 mg once daily 1
- Titration: Gradually increase at weekly intervals until optimal response or pronounced heart rate slowing
- Maximum studied dose: 400 mg daily 1
- Discontinuation: Taper gradually over 1-2 weeks to avoid rebound 1
Heart Failure with Reduced Ejection Fraction (HFrEF)
This requires the most careful titration approach:
Starting doses 1:
- NYHA Class II: 25 mg once daily for 2 weeks
- NYHA Class III-IV: 12.5 mg once daily for 2 weeks
Titration protocol 1:
- Double the dose every 2 weeks as tolerated
- Target dose: 200 mg once daily 4, 5, 6
- Mean dose achieved in clinical trials: 159 mg daily 5, 6
Critical management points 1:
- Stabilize diuretics, ACE inhibitors, and digitalis before initiating
- If transient worsening occurs, increase diuretics first and temporarily reduce metoprolol if necessary
- Do not increase dose until heart failure symptoms stabilize
- For symptomatic bradycardia, reduce dose but discontinue only if clearly necessary
- Initial titration difficulty should not prevent later attempts
Post-STEMI
For acute myocardial infarction, the 2013 ACCF/AHA STEMI guidelines recommend 7:
- Metoprolol tartrate: 25-50 mg every 6-12 hours orally initially
- Transition over 2-3 days to twice-daily metoprolol tartrate OR once-daily metoprolol succinate
- Target: Titrate to 200 mg daily as tolerated 7
- IV metoprolol tartrate: 5 mg every 5 minutes as tolerated (up to 3 doses) for refractory hypertension or ongoing ischemia, titrated to heart rate and blood pressure 7
Important Clinical Considerations
Bioequivalence: The same total daily dose should be used when switching from immediate-release metoprolol to metoprolol succinate extended-release 1. However, metoprolol succinate produces lower peak levels (one-fourth to one-half) with longer time to peak compared to immediate-release formulations 1.
Pharmacokinetics: Metoprolol succinate provides 77% bioavailability relative to immediate-release metoprolol, with sustained beta-blockade over 24 hours despite lower peak concentrations 1. Food does not significantly affect bioavailability 1.
Target dose importance: Evidence strongly suggests that achieving target doses (200 mg daily for heart failure) provides superior outcomes compared to medium-range doses 8. The dose-response relationship is not flat—higher tolerated doses yield greater benefits 8.
Common pitfall: Many clinicians use doses appropriate for hypertension (25-100 mg daily) when treating heart failure, where the evidence-based target is 200 mg daily 8. The optimal dose for heart failure exceeds typical hypertension dosing 8.